FDA Expands Wegovy Label to Include Heart Disease Risk Reduction

Key points

• The FDA approved Wegovy to cut the risk of serious heart attacks and strokes in adults with heart disease and high BMI.
• The cardiovascular designation helps pave the way for expanded coverage under private health insurance and Medicare.
• Widespread adoption of GLP-1 medications continues to influence menu planning and consumer trends across the food sector.
• Manufacturing shortages remain a bottleneck as pharmaceutical producers race to build out global supply lines.

This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.

Sources and methodology

Reported from the public datasets below.

• Bureau of Labor Statistics (BLS) - Consumer Price Index, food away from home
• Federal Reserve Economic Data (FRED) - Food services and drinking places series
• U.S. Census Bureau - Monthly Retail Trade, food services

All sources Foodie Pundit reports from

More from the Foodie Pundit Newsroom

• Kroger Deepens Home Chef Partnership to Target Busy Diners Seeking Ultra-Convenient Meal Options
• LIME TIME: 7Up Gets a Zesty Makeover to Reclaim Its Fizz
• FDA Approves Wegovy for Heart Disease Prevention as GLP-1 Market Expands
• Kroger Expands Home Chef Ready-to-Eat Line to Challenge Fast Casual Dining
• The End of Solitary Dining Shifts Restaurant Economics and Menu Design